Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse , today announced...

Related Keywords

United States ,Richie Cunningham ,Bimal Shah ,Company Or Anebulo ,Nasdaq ,Anebulo Pharmaceuticals Inc ,Securities Exchange ,Anebulo Pharmaceuticals ,Quarter Fiscal Year ,Subsequent Highlights ,Chief Executive Officer ,States Adopted Names ,Board Member ,Emergency Departments ,Securities Act ,Securities Exchange Act ,Quarterly Report ,Months Ended December ,Markets ,